Gainers
• Genprex, Inc. GNPX shares rose 48.7% to $1.71 during Wednesday's pre-market session.
• Akcea Therapeutics, Inc. AKCA shares moved upwards by 16.6% to $20.21. The most recent rating by BMO Capital, on November 06, is at Outperform, with a price target of $36.00.
• Advaxis, Inc. ADXS stock surged 5.8% to $1.10.
• Moderna, Inc. MRNA stock increased by 5.3% to $22.05. The most recent rating by Bank of America, on December 03, is at Buy, with a price target of $29.00.
• BioLine Rx, Inc. BLRX stock surged 4.0% to $2.59.
Losers
• Novavax, Inc. NVAX shares plummeted 13.4% to $8.50 during Wednesday's pre-market session.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.